|
| 37184202 | Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase. | | 2023 |
| 36070707 | Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B. | Digestive Diseases | 2023 |
| 37734582 | Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study. | | 2023 |
| 37882252 | Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study. | | 2023 |
| 37273170 | Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study. | | 2023 |
| 34822056 | Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study. | Hepatol Int | 2022 |
| 36070123 | Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort. | Hepatol Int | 2022 |
| 36123845 | Endoscopic evaluation during the COVID-19 pandemic: Observational study of the experience in community practices. | Medicine (United States) | 2022 |
| 33486083 | Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort. | Clinical Gastroenterology and Hepatology | 2022 |
| 34059991 | Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV. | Digestive Diseases and Sciences | 2022 |
| 33465482 | Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase. | Clinical Gastroenterology and Hepatology | 2022 |
| 33775894 | Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study. | Clinical Gastroenterology and Hepatology | 2022 |
| 34089852 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine. | Clin Gastroenterol Hepatol | 2022 |
| 33394321 | Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. | Hepatol Int | 2021 |
| 33706421 | Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice. | Hepatology | 2021 |
| 34074829 | Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir. | American Journal of Gastroenterology | 2021 |
| 34219250 | Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C. | Journal of Medical Virology | 2021 |
| 33999179 | Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. | Journal of Infectious Diseases | 2021 |
| 34141981 | Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study. | Hepatol Commun | 2021 |
| 33547557 | One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. | Hepatology International | 2021 |
| 33249474 | Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B. | Journal of Infectious Diseases | 2021 |
| 32525978 | Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B. | Journal of Infectious Diseases | 2021 |
| 32836224 | Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. | Digestive Diseases | 2021 |
| 31550363 | Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy. | Journal of Infectious Diseases | 2020 |
| 32129773 | Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis. | European Journal of Gastroenterology and Hepatology | 2020 |
| 31634265 | Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B. | American Journal of Gastroenterology | 2020 |
| 32087795 | Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study. | Lancet Gastroenterol Hepatol | 2020 |
| 33094953 | Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients. | Clinical and Translational Gastroenterology | 2020 |
| 30930022 | Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis. | Gastroenterology | 2019 |
| 29982737 | Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study. | J Infect Dis | 2019 |
| 30342034 | Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis. | Gastroenterology | 2019 |
| 30238203 | A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study. | Dig Dis Sci | 2019 |
| 30326298 | Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices. | Clinical Gastroenterology and Hepatology | 2019 |
| 30467877 | Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir. | Alimentary Pharmacology and Therapeutics | 2019 |
| 29756595 | 96⿯weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. | Journal of Hepatology | 2018 |
| 28733260 | Significant Hepatic Fibrosis Among Treatment-Naive Chronic Hepatitis B Virus With Increased Hepatitis B Virus DNA and Normal Alanine Aminotransferase. | Clinical Gastroenterology and Hepatology | 2018 |
| 28323748 | Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B. | Journal of Clinical Gastroenterology | 2018 |
| 30288329 | Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. | | 2018 |
| 27677786 | Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States. | Journal of Viral Hepatitis | 2017 |
| 28581644 | Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study. | Journal of Viral Hepatitis | 2017 |
| 28792897 | Partial Membership Latent Dirichlet Allocation for Soft Image Segmentation. | | 2017 |
| 28440303 | HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis. | American Journal of Gastroenterology | 2017 |
| 29087397 | Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients. | American Journal of Gastroenterology | 2017 |
| 27583921 | Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. | Medicine (Baltimore) | 2016 |
| 27325221 | Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. | Am J Gastroenterol | 2016 |
| 27363288 | Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection. | Aliment Pharmacol Ther | 2016 |
| 27210427 | Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B. | J Hepatol | 2016 |
| 27456990 | Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B. | American Journal of Gastroenterology | 2016 |
| 26018133 | Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice. | Journal of Clinical Gastroenterology | 2016 |
| 26660679 | Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. | Dig Dis Sci | 2016 |